Fig. 3: DUSP2 is a target of miR-361-3p.

a Intersections among four miRNA target prediction algorithms. b Schematic representation of DUSP2 3′ UTR indicating the predicted binding site of miR-361-3p. c–f Relative expression of DUSP2 mRNA and protein after treatment with miR-361-3p mimic or inhibitor. g Schematic diagram of the luciferase reporter plasmids of pMIR-wild type-DUSP2 3′ UTR and pMIR-mutant-DUSP2 3′ UTR. h, i Luciferase activity assays was performed to confirm the direct binding efficiency of miR-361-3p and its putative target DUSP2. j Representative images of immunohistochemistry analyses to detect the DUSP2 protein in orthotopic tumors from negative control and miR-361-3p knockdown group. Data are shown as the mean ± SD of three replicates; *P < 0.05; **P < 0.01; ***P < 0.001; ns not significant